Cell Culture Market- Snapshot

Cell culture is the process of removal of living cells from a plant or animal and growing these cells in an artificial, controlled environment. The trend of cell culture is rapidly being adopted in the field of pharmaceuticals. In 2016, the global market for cell culture was valued at US$ 13,000.0 Mn and is expected to expand at a CAGR of 10.0% from 2017 to 2025. Manufacture of biopharmaceuticals involves use of cell culture systems as a unique method of product development, as these products are difficult to be produced by using the conventional process of pharmaceutical development. Research and development in the field of biopharmaceuticals, which concentrates on the discovery of new therapeutics for rare diseases and new mechanisms of drug action, has increased the scope for use of cell culture in biologics.

cell-culture-market.jpg

Cell culture is used in a wide range of applications such as development of model systems for research, analysis of cellular structures and their mechanisms, discovery of drugs for the treatment of diseases (such as Alzheimer’s disease), stem cell research, drug evaluation, genetic engineering, and production of biologics such as antibodies, vaccines, and proteins. Applications such as stem cell research offer high potential for growth of the cell culture market in the near future. Stem cell culture assists in the standardization of drug production and enables production of a wide variety of cell lines and related products. Traditional pharmaceutical therapeutics help in treating only disease symptoms, whereas stem cell therapies assist in treating the cause of the disease. Thus, further research in the field of stem cell culture for the development of drugs offers high potential for the market in the near future.

The global cell culture market can be segmented in terms of product, end-user, and geography. Based on product, the global cell culture market can be categorized into instruments, mediums, sera, and reagents. The instruments segment has been sub-categorized into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. The mediums segment has been sub-segmented into chemically defined mediums, classical mediums, protein-free mediums, lysogeny broths, serum-free mediums, and specialty mediums. The sera segment has been sub-divided into fetal bovine serum and others. The reagents segment has been sub-segmented into albumin, amino acids, attachment factors, growth factors & cytokines, protease inhibitors, thrombin, and others. With the increasing trend toward use of animal-derived, component-free mediums and adoption of chemically defined and specialty mediums; the market for cell culture is likely to witness significant growth in the near future. On the other hand, automation of cell culture systems requires more sophisticated instruments and equipment. This factor is projected to drive the instruments segment in the next few years.

Geographically, the cell culture market in Asia Pacific is likely to expand at a high CAGR during the forecast period. Rise in outsourcing activities and expansion by biopharmaceutical manufacturers in this region are expected to drive the market in Asia Pacific during the forecast period. Moreover, low cost of manufacturing in China and India has resulted in the rise in the number of production facilities, attracting large pharmaceutical and biotechnological companies from across the world toward Asia Pacific.

A majority of the cell culture products are being manufactured by market players such as Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, GE Healthcare, Corning Incorporated, Becton, Dickinson and Company, Merck KGaA, Lonza, VWR International LLC, and PromoCell GmbH. Leading players have established their position in the market and they enjoy brand loyalty among customers. These manufacturers have a wide product range to offer and have an extensive distribution network across the world. In addition, a number of small players are entering the emerging markets of Asia, Middle East, and Latin America. However, stringent regulatory framework and high quality standards set by market leaders may limit the speed of market penetration by new entrants.

Global Cell Culture Market: Overview

This report on the cell culture market analyzes the current and future scenario of the global market. Increasing product development, rising demand for biologic therapeutics, and growing research on stem cells are major drivers for the global cell culture market.

This report on the global cell culture market comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on product, end-user, and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises competitive matrix and company profiles with business overview to understand the competition landscape in the market. This section of the report also provides market attractiveness analysis, by geography, and market share analysis, by key player; thereby presenting a thorough analysis of the overall competition scenario in the global cell culture market.

Global Cell Culture Market: Key Segments

Based on product, the market has been segmented into instruments, mediums, sera, and reagents. Product segments have been analyzed based on product categories available in the cell culture market, their cost-effectiveness, and preference for industries. The instruments segment has been sub-categorized into cell culture vessels (bioreactors), carbon dioxide incubators, biosafety cabinets, cryogenic tanks, and others. The mediums segment has been sub-segmented into chemically defined mediums, classical mediums, lysogeny broths, serum-free mediums, protein–free mediums, and specialty mediums. The sera segment has been sub-divided into fetal bovine serum (FBS) and others. The reagents segment has been sub-categorized into growth factors & cytokines, albumin, protease inhibitors, thrombin, attachment factors, amino acids, and others.

Based on end-user, the global cell culture market has been segmented into biotechnology companies, pharmaceutical companies, academic institutes, and research institutes. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global Cell Culture Market: Regional Outlook

Geographically, the global cell culture market has been segregated into five major regions and key countries/sub-regions in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa). The market size and forecast for each of these regions and countries/sub-regions have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competition scenario in these regions.

Companies mentioned in Report

The report also profiles major players in the global cell culture market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players operating in the global cell culture market are Sartorius AG, Thermo Fisher Scientific Inc., Eppendorf AG, GE Healthcare, Corning Incorporated, Becton, Dickinson and Company, Merck KGaA, Lonza, VWR International LLC, and PromoCell GmbH.

The global cell culture market has been segmented as given below:

  • Global Cell Culture Market, by Product, 2015–2025
    • Instruments
      • Cell Culture Vessels (Bioreactors)
      • Carbon Dioxide Incubators
      • Biosafety Cabinets
      • Cryogenic Tanks
      • Others
    • Mediums
      • Chemically Defined Mediums
      • Classical Mediums
      • Lysogeny Broths
      • Serum-free Mediums
      • Protein-free Mediums
      • Specialty Mediums
    • Sera
      • Fetal Bovine Serum (FBS)
      • Others
    • Reagents
      • Growth Factors & Cytokines
      • Albumin
      • Protease Inhibitors
      • Thrombin
      • Attachment Factors
      • Amino Acids
      • Others
  • Global Cell Culture Market, by End-user, 2015–2025
    • Biotechnology Companies
    • Pharmaceutical Companies
    • Academic Institutes
    • Research Institutes
  • Global Cell Culture Market Revenue, by Geography, 2015–2025
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • Italy
      • France
      • Spain
      • Rest of Europe
    • Asia Pacific
      • India
      • China
      • Japan
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • GCC
      • South Africa
      • Rest of Middle East & Africa